Fast Track Protocol After Radical Cystectomy and Urinary Diversion: A Randomised Controlled Trial.
Primary Purpose
Bladder Cancer
Status
Unknown status
Phase
Phase 3
Locations
Egypt
Study Type
Interventional
Intervention
Fast Track Protocol
Sponsored by
About this trial
This is an interventional treatment trial for Bladder Cancer focused on measuring ERAS (Early Recovery After Surgery), Radical Cystectomy
Eligibility Criteria
Inclusion Criteria:
- Patients undergoing radical cystectomy and urinary diversion surgery including orthotopic neobladder and ileal loop conduit
Exclusion Criteria:
- Radical cystectomy performed in an emergency setting
- Patients who refused fast track protocol
- Mental illnesses
Sites / Locations
- Mansoura Urology & Nephrology Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Fast Track Protocol
Conventional perioperative care program
Arm Description
the 22 items of ERAS (Early Recovery After Surgery) society
standard perioperative care
Outcomes
Primary Outcome Measures
Length of hospital stay.
Mean length of hospital stay defined as days from admission to the hospital, in both groups 1 day before surgery and discharge.
Secondary Outcome Measures
Early postoperative complications rate defined and graded according to Clavien-Dindo system.
Rate of early postoperative complications eg: anastomotic leakage, intestinal obstruction, wound infection.
Hospital readmission rate.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT04939194
Brief Title
Fast Track Protocol After Radical Cystectomy and Urinary Diversion: A Randomised Controlled Trial.
Official Title
Fast Track Protocol After Radical Cystectomy and Urinary Diversion: A Randomised Controlled Trial.
Study Type
Interventional
2. Study Status
Record Verification Date
June 2021
Overall Recruitment Status
Unknown status
Study Start Date
January 15, 2021 (Actual)
Primary Completion Date
January 1, 2023 (Anticipated)
Study Completion Date
July 1, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Mansoura University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
We will design a randomized controlled single center study in which we will compare 2 groups of patients, 1 with standard perioperative protocols and another one in which we will apply fast track protocols in patients after radical cystectomy and urinary diversion .
Detailed Description
Study hypothesis:
Fast Track Protocol after Radical Cystectomy reduces the length of hospital stay and the early postoperative complications relative to the traditional perioperative care regimen.
Purpose of the study:
To evaluate the the perioperative efficacy, safety and benefits of fast track protocol implementation after radical cystectomy and to optimize perioperative patient care for the benefit of "fast-track" surgery.
To evaluate early complications in patients with bladder cancer who will be subjected to radical cystectomy and urinary diversion.
Study groups:
Group 1: Fast Track group (105 patients). Group 2: Conventional perioperative care group (105 patients).
Study design:
The design of the research will be a prospective randomised, open-label, controlled study on 210 consecutive patients with bladder cancer who will be subjected to radical cystectomy and urinary diversion. All the patients will sign an informed consent. Length of stay, dietary issues, and return of bowel function, readmission rates and complications will be evaluated.
Study setting/location:
The study will be conducted in a single tertiary centre, Urology and Nephrology Centre in Mansoura, Egypt. The study will be carried out on patient with bladder cancer who will be subjected to radical cystectomy and urinary diversion.
Study duration:
The study will last about 2 and half years.
Randomisation:
Randomization will be performed using computer generated, sequentially numbered random tables. Ratio of assignment to groups is 1: 1.
Allocation concealment and blinding:
We are well aware that it is very difficult to properly blind trials comparing surgical treatments. Allocation of patients to treatment groups will be self-evident following randomization and blinding of patient groups and observers will not be possible. So, our trial will be a randomised, open-label, controlled trial.
Type of analysis:
Intention-to-treat analysis is planned in this trial. We will include all patients randomized to the fast track group regardless of their adherence and compliance to the early recovery after surgery (ERAS) items.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bladder Cancer
Keywords
ERAS (Early Recovery After Surgery), Radical Cystectomy
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
200 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Fast Track Protocol
Arm Type
Experimental
Arm Description
the 22 items of ERAS (Early Recovery After Surgery) society
Arm Title
Conventional perioperative care program
Arm Type
No Intervention
Arm Description
standard perioperative care
Intervention Type
Behavioral
Intervention Name(s)
Fast Track Protocol
Intervention Description
We will apply 22 items of ERAS society
Primary Outcome Measure Information:
Title
Length of hospital stay.
Description
Mean length of hospital stay defined as days from admission to the hospital, in both groups 1 day before surgery and discharge.
Time Frame
3 months after surgery.
Secondary Outcome Measure Information:
Title
Early postoperative complications rate defined and graded according to Clavien-Dindo system.
Description
Rate of early postoperative complications eg: anastomotic leakage, intestinal obstruction, wound infection.
Time Frame
3 months after surgery.
Title
Hospital readmission rate.
Time Frame
3 months after surgery.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients undergoing radical cystectomy and urinary diversion surgery including orthotopic neobladder and ileal loop conduit
Exclusion Criteria:
Radical cystectomy performed in an emergency setting
Patients who refused fast track protocol
Mental illnesses
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ahmed Mosbah, Prof.
Organizational Affiliation
Urology department , Urology and Nephrology Center , Faculty of Medicine, Mansoura University, Egypt
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Mahmoud Laymon, Lecturer.
Organizational Affiliation
Urology department , Urology and Nephrology Center , Faculty of Medicine, Mansoura University, Egypt
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Ahmed Lashin, Dr.
Organizational Affiliation
Urology department , Urology and Nephrology Center , Faculty of Medicine, Mansoura University, Egypt
Official's Role
Principal Investigator
Facility Information:
Facility Name
Mansoura Urology & Nephrology Center
City
Mansoura
ZIP/Postal Code
35516
Country
Egypt
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Fast Track Protocol After Radical Cystectomy and Urinary Diversion: A Randomised Controlled Trial.
We'll reach out to this number within 24 hrs